US FDA News: FDA Approves First Adjuvant Therapy for Most Common Type of Lung Cancer

Today, the FDA approved the first adjuvant treatment for patients with non-small cell lung cancer whose tumors have a specific type of genetic mutation.
Read more: FDA Approves First Adjuvant Therapy for Most Common Type of Lung Cancer